报价延迟最少15分钟:2026/04/04 02:28 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
63.57 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
8.88/6.65
|
|
企业价值
16.20B
|
| 资产负债 |
|
每股账面净值
29.12
|
| 现金流量 |
|
现金流量率
0.03
|
| 损益表 |
|
收益
8.33B
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally. |
